Persistent diffuse diabetic macular edema. The role of the internal limiting membrane as a selective membrane: The oncotic theory

Medical Hypotheses

Volumn 76, Issue 6, 2011, Pages 858-860

  Saravia, Mario ^a  

^a UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLLOID; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; HUMAN; INTERNAL LIMITING MEMBRANE; LOW LEVEL LASER THERAPY; MEMBRANE; MEMBRANE STRUCTURE; METABOLIC REGULATION; ONCOTIC PRESSURE; ONCOTIC THEORY; SURGICAL TECHNIQUE; THEORY; VISUAL IMPAIRMENT; VITRECTOMY;

DIABETES COMPLICATIONS; HUMANS; MACULAR EDEMA; MODELS, THEORETICAL; VITRECTOMY;

EID: 79955726614     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.02.036     Document Type: Article

References (15)

1. Lewis H., Abrams G.W., Blumenkranz M.S., Campo R.V. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992, 99:753-759.
2. Yamamoto T., Hitani K., Sato Y., Yamashita H., Takeuchi S. Vitrectomy for diabetic macular edema with and without internal limiting membrane removal. Ophthalmologica 2005, 219:206-213.
3. Figueroa M.S., Contreras I., Noval S. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina 2008, 28:420-426.
4. Laidlaw D.A. Vitrectomy for diabetic macular oedema. Eye (Lond.) 2008, 22:1337-1341.
5. Rosenblatt B.J., Shah G.K., Sharma S., Bakal J. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol 2005, 243:20-25.
6. Tachi N., Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996, 122:258-260.
7. Gandorfer A., Messmer E.M., Ulbig M.W., Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000, 20:126-133.
8. Stefaniotou M., Aspiotis M., Kalogeropoulos C., et al. Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 2004, 14:137-143.
9. Stefansson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 2006, 51:364-380.
10. Gandorfer A., Rohleder M., Grosselfinger S., Haritoglou C., Ulbig M., Kampik A. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 2005, 139:638-652.
11. Lopes de Faria J.M., Jalkh A.E., Trempe C.L., McMeel J.W. Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol Scand 1999, 77:170-175.
12. Klein R., Knudtson M.D., Lee K.E., Gangnon R., Klein B.E. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009, 116:497-503.
13. Rand L.I., Prud'homme G.J., Ederer F., Canner P.L. Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) report no. 10. Invest Ophthalmol Vis Sci 1985, 26:983-991.
14. Mordenti J., Thomsen K., Licko V., et al. Intraocular pharmacokinetics and safety of a humanized monoclonal antibody in rabbits after intravitreal administration of a solution or a PLGA microsphere formulation. Toxicol Sci 1999, 52:101-106.
15. Matsunaga N., Ozeki H., Hirabayashi Y., Shimada S., Ogura Y. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina 2005, 25:311-316.